About Globus Medical, Inc.
https://www.globusmedical.comGlobus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.
CEO
Keith W. Pfeil
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 214
Ratings Snapshot
Rating : A
Most Recent Analyst Grades
Canaccord Genuity
Buy
Truist Securities
Buy
B of A Securities
Buy
Stifel
Buy
RBC Capital
Outperform
Morgan Stanley
Overweight
Grade Summary
Showing Top 6 of 13
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:10.61M
Value:$980.61M
BLACKROCK, INC.
Shares:10.53M
Value:$973.91M
BLACKROCK INC.
Shares:10.34M
Value:$956.02M
Summary
Showing Top 3 of 638
About Globus Medical, Inc.
https://www.globusmedical.comGlobus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $769.05M ▲ | $351.66M ▼ | $118.97M ▼ | 15.47% ▼ | $0.88 ▼ | $215.12M ▲ |
| Q2-2025 | $745.34M ▲ | $420.47M ▲ | $202.85M ▲ | 27.22% ▲ | $1.5 ▲ | $193.44M ▲ |
| Q1-2025 | $598.12M ▼ | $305.72M ▼ | $75.46M ▲ | 12.62% ▲ | $0.55 ▲ | $164.13M ▲ |
| Q4-2024 | $657.29M ▲ | $333.58M ▲ | $26.5M ▼ | 4.03% ▼ | $0.19 ▼ | $145.28M ▲ |
| Q3-2024 | $625.71M | $307.09M | $51.84M | 8.28% | $0.38 | $115.94M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $390.52M ▲ | $5.1B ▲ | $696.82M ▲ | $4.4B ▲ |
| Q2-2025 | $229.45M ▼ | $4.96B ▲ | $665.41M ▲ | $4.3B ▲ |
| Q1-2025 | $461.27M ▼ | $4.71B ▼ | $623.08M ▼ | $4.09B ▼ |
| Q4-2024 | $890.06M ▲ | $5.25B ▲ | $1.07B ▲ | $4.18B ▲ |
| Q3-2024 | $694.71M | $5.09B | $1.02B | $4.07B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $118.97M ▼ | $249.69M ▲ | $-75.84M ▲ | $-32.04M ▼ | $142.32M ▲ | $218.88M ▲ |
| Q2-2025 | $202.85M ▲ | $77.86M ▼ | $-299.11M ▼ | $-24.94M ▲ | $-231.82M ▲ | $31.3M ▼ |
| Q1-2025 | $75.46M ▲ | $177.3M ▼ | $131.38M ▲ | $-635.4M ▼ | $-323.17M ▼ | $136.2M ▼ |
| Q4-2024 | $26.5M ▼ | $210.34M ▲ | $-104.12M ▼ | $59.73M ▲ | $161.67M ▼ | $193.23M ▲ |
| Q3-2024 | $51.84M | $203.65M | $-14.97M | $19.58M | $212.34M | $161.7M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Emerging Technology | $50.00M ▲ | $20.00M ▼ | $40.00M ▲ | $30.00M ▼ |
 Spine | $610.00M ▲ | $580.00M ▼ | $710.00M ▲ | $740.00M ▲ |
Revenue by Geography
| Region | Q4-2024 | Q2-2025 | Q1-2025 | Q3-2025 |
|---|---|---|---|---|
 NonUS | $140.00M ▲ | $140.00M ▲ | $110.00M ▼ | $150.00M ▲ |
 UNITED STATES | $520.00M ▲ | $600.00M ▲ | $480.00M ▼ | $620.00M ▲ |
CEO
Keith W. Pfeil
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 214
Ratings Snapshot
Rating : A
Most Recent Analyst Grades
Canaccord Genuity
Buy
Truist Securities
Buy
B of A Securities
Buy
Stifel
Buy
RBC Capital
Outperform
Morgan Stanley
Overweight
Grade Summary
Showing Top 6 of 13
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:10.61M
Value:$980.61M
BLACKROCK, INC.
Shares:10.53M
Value:$973.91M
BLACKROCK INC.
Shares:10.34M
Value:$956.02M
Summary
Showing Top 3 of 638